GUBRA A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 485 DKK | +11.24% |
|
+46.97% | +288.00% |
| 07/05 | Gubra A/S Announces Management Changes | CI |
| 17/04 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GUBRA A/S | Bio Therapeutic Drugs | +11.24% | +46.97% | +288.00% | +435.91% | - | 113.16Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GUBRA Stock
- Charts Gubra A/S
- Comparison Chart
